ResearcherKeele UniversityActive in the last 2 years
Clare Hoskins
Matched on ORCID iD 0000-0002-7200-0566; OpenAlex author ID A5024051154. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 1, last author 7)
- Trials
- 0
- Grants
- 0
- Labs led
- 2
- Collaborators
- 12
2017: 3 papers · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 3 papers · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 9
- Developments & Potential of Nanotechnology for the Detection and Treatment of Pancreatic Cancer. First author DOI 10.2147/ijn.s559038↗
- Solid lipid nanoparticles in pancreatic cancer treatment. Last author DOI 10.1038/s44276-025-00130-9↗
- Liposome-based diagnostic and therapeutic applications for pancreatic cancer. Co-author DOI 10.1016/j.actbio.2022.12.013↗
- Chain length impact on the retro Diels-Alder mediated release of gemcitabine from hybrid nanoparticles towards pancreatic cancer therapy. Last author DOI 10.1016/j.ijpharm.2023.123304↗
- Small-scale particles showing large-scale impact in pancreatic cancer. Last author DOI 10.2217/nnm-2023-0283↗
- A Novel PAA Derivative with Enhanced Drug Efficacy in Pancreatic Cancer Cell Lines. Last author DOI 10.3390/ph11040091↗
- Diels Alder-mediated release of gemcitabine from hybrid nanoparticles for enhanced pancreatic cancer therapy. Last author DOI 10.1016/j.jconrel.2017.09.027↗
- Thermally triggered theranostics for pancreatic cancer therapy. Last author DOI 10.1039/c7nr02751f↗
- Nanotechnologies in Pancreatic Cancer Therapy. Last author DOI 10.3390/pharmaceutics9040039↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Danielle O'Meara · 1 shared paper, 2026 · strength 0.63
- Mia Dunn · 1 shared paper, 2025 · strength 0.42
- Adeolu Oluwasanmi · 3 shared papers, 2017–2023 · strength 0.40
- Paper Chain length impact on the retro Diels-Alder mediated release of gemcitabine from hybrid nanoparticles towards pancreat… DOI 10.1016/j.ijpharm.2023.123304↗
- Paper Nanotechnologies in Pancreatic Cancer Therapy. DOI 10.3390/pharmaceutics9040039↗
- Paper Diels Alder-mediated release of gemcitabine from hybrid nanoparticles for enhanced pancreatic cancer therapy. DOI 10.1016/j.jconrel.2017.09.027↗
- Arza Izzadeen · 1 shared paper, 2023 · strength 0.31
- Faisal Raza · 1 shared paper, 2023 · strength 0.17
- Diana Peixoto · 1 shared paper, 2023 · strength 0.17
- Miguel Pereira‐Silva · 1 shared paper, 2023 · strength 0.17
- Abbas Rahdar · 1 shared paper, 2023 · strength 0.17
- Ana Cláudia Paiva‐Santos · 1 shared paper, 2023 · strength 0.17
- Ayesha Manzur · 2 shared papers, 2017 · strength 0.16
- Ali Alsuraifi · 1 shared paper, 2018 · strength 0.11
- Maryam Malekigorji · 1 shared paper, 2017 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.